Glycyrrhetinic acid (Ia) (Fig. 1) , the aglycone of glycyr rhizin isolated from licorice root (Glycyrrhiza), has been established to have various pharmacological activities such as anti-inflammatory (1, 2), anti-tumorigenic (3) and anti-hepatotoxic (4) as well as inhibitory activities against hepatic and renal 11,3-hydroxysteroid dehydrogenase (5) and growth of mouse melanoma (6). Glycyrrhetinic acid derivatives have been prepared to enhance the therapeutic effects and suppress adverse actions (pseudo-aldosteron ism) of the parent compound (7). Clinically, glycyrrhetinic acid 313-O-hemiphthalate sodium (Ib) has been found to reduce pain with a transdermal 10010 lidocaine base gel (8). We have previously reported that deoxoglycyrrhetol dihemiphthalate (IIb) and the related compounds (IIIa and IVa) inhibit leukotrienes and prostaglandin E2 syn thesis in vitro (9) and in vivo (10, 11), and edema forma tion induced by inflammatory agents such as arachidonic acid (10), 12-O-tetradecanoylphorbol-13-acetate (TPA) (12) and carrageenan (13). Furthermore, these com pounds have been found to prevent experimental gastric ulcer by strengthening gastric mucosal defense mecha nisms, which were independent of the protective effect of prostaglandins (14). Recently, some other workers have reported that the di-sodium salts of the dihemi phthalates of urs-12-ene-3,3,28-diol and ursa-9(11),12 diene-3j3,28-diol derived from uvaol are effective anti ulcer agents (15).
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Neurogenic inflammatory responses such as axon reflex vasodilatation, plasma extravasation and mast cell acti vation are induced by stimulation of capsaicin-sensitive afferent neurons that contain neuropeptides including substance P (SP) as neurotransmitters (16, 17) . Topical application of capsaicin, the primary pungent ingredient of red peppers, to the ear of mouse produces neurogenic skin inflammation (18) (19) (20) . Previous studies have demonstrated that capsaicin-induced mouse ear edema is inhibited by tachykinin NK,-receptor antagonists, hista mine and/or serotonin antagonists, but not by inhibitors of arachidonate metabolites such as indomethacin, nordi hydroguaiaretic acid and AA 861 (20) (21) (22) . In this study, we examined the effect of glycyrrhetinic acid and its derivatives on capsaicin-induced mouse ear edema.
MATERIALS AND METHODS

Animals
Six-week-old male ddY mice weighing 30-35 g (Japan SLC, Hamamatsu) or nine-week-old male WBB6F1-W/ W" mice weighing 25-31 g (Japan SLC) were used for the experiments. The animals were kept in an environmental ly controlled room (24±1'C, 55:E10% humidity) and allowed free access to food and water. Capsaicin-induced mouse ear edema Induction of mouse ear edema was performed as reported previously (20) . Animals were conscious when tested. Capsaicin was dissolved in acetone at a concentra tion of 12.5 mg/ml, and 20 pl (250 pg/ear) was then ap plied topically to both surfaces of an ear of each mouse. The magnitude of edema was assessed by measuring the thickness at the edge of ear before and 30 min after cap saicin treatment in units of 0.001 mm with dial calipers (Ozaki Factory, Tokyo). Ear edema was expressed as the increase in ear thickness. Mice were anesthetized with pentobarbital sodium (50 mg/kg, i.p.). Plasma extravasation was induced by i.v. injection of SP at a dose of 5 rig/kg, together with Evans blue (60 mg/kg; Wako Pure Chemical Industries, Osaka) used as a marker. Control mice for SP received saline and Evans blue. Thirty minutes later, the animals were killed by cervical dislocation, and an ear was removed by cut ting across the indentation at the base of the ear. The ear was weighed and dissolved with 0.7 ml of 1 N potassium hydroxide at 371C for 18 hr, and then it was added with 4.3 ml of a mixture of 0.6 N phosphoric acid and acetone (5 : 13). After vigorous shaking, the mixture was cen trifuged at 3,500 x g for 20 min. The dye in the super natant was measured by spectrophotometry at 620 nm. Plasma extravasation was expressed as pg of Evans blue per 100 mg of wet tissue. yl-2-(1-imino-2-(2-methoxyphenyl) ethyl) perhydroiso indol-4-one) was the generous gift of Rhone-Poulenc Rorer, Vitry sur Seine, France. Glycyrrhetinic acid and its derivatives were dissolved or suspended with 1010 polyoxy ethylene sorbitan mono-oleate (Tween 80; Tokyo Kasei Chemical Industry, Tokyo). RP 67580 was initially dis solved in 0.1 N methanesulfonic acid and diluted in saline (Fig. 2) , respectively. Glycyrrhetinic acid (Ia), glycyrrhetinic acid 3~-O-hemiphthalate sodium (Ib) and deoxoglycyrrhetol (IIa) at a dose of 200 mg/kg (p.o.) had little effect on the edema formation. Chlorphen iramine (4 mg/kg, i.v.), a histamine H, blocker, exhibited a slight, but significant inhibition of capsaicin-induced edema. Furthermore, RP 67580 (0.1 and 0.5 mg/kg, i.v.), a tachykinin NK1-receptor antagonist, was very effective in suppressing the edema response to capsaicin. The ED50 value of RP 67580 is 0.19 mg/kg (21). Com pounds IIb, IIIa and IVa had no effect on ear thickness in normal mice. Examination of the hematoxylin and eosin-stained sections clearly revealed the edema response in the dermis following topical application of capsaicin (Fig. 3a) . Com pound IIIa at a dose of 50 mg/kg (p.o.) markedly diminished the increase in the thickness of the epidermis (Fig. 3b) . Application of capsaicin to the ear causes degranulation of mast cells in skin connective tissue, although capsaicin itself does not induce mast cell degranulation directly (22). However, toluidine blue sec tions showed that compound IIIa did not prevent degranulation of mast cells in the tissue of capsaicin treated ears (H. Inoue, unpublished data). Effects of compound IIIa on ear edema induced by cap saicin in mast cell-deficient mice
The edema response to capsaicin in mast cell-deficient mice (WBB6F1-W/W") was decreased up to 36%, com pared with that in the control mice (WBB6F1-+/+) (H. Inoue, unpublished data). Compound IIIa at a dose of 100 mg/kg (p.o.) diminished the response to capsaicin in mast cell-deficient mice ( (Fig. 4) . Moreover, these compounds at a dose of 100 mg/kg prevented plasma extravasation induced by i.v. administration of SP (5 pg/kg) (Fig. 5) . However, glycyrrhetinic acid at 200 mg/kg (p.o.) (la) was ineffective in suppressing both responses to SP. The test compounds themselves did not modify the base level of plasma ex travasation (H. Inoue, unpublished data). Chlorphen iramine (4 mg/kg, i.v.) significantly inhibited SP-induced ear edema but had little effect on plasma extravasation. Both responses to SP were markedly suppressed by pretreatment with RP 67580 (0.5 mg/kg, i.v.). 
DISCUSSION
Deoxoglycyrrhetol dihemiphthalate (IIa) and the re lated compounds (IIIa and IVa), the glycyrrhetinic acid derivatives with hemiphthalate groups at the 3 and 30 positions of rings A and E in the oleanane skeleton, in hibited mouse ear edema induced by capsaicin, SP and compound 48/80, whereas glycyrrhetinic acid (Ia) (and deoxoglycyrrhetol (IIa)), the parent compounds of the dihemiphthalate derivatives, had no effect on these models. Thus, it appears that the anti-inflammatory profile of the three compounds (IIb, IIIa and IVa) is quite different from that of glycyrrhetinic acid. Compound (Ib) with a hemiphthalate group at the 3-position of ring A was weakly effective in inhibiting capsaicin-induced ear edema. These results suggest that the dihemiphthalate substitution on the oleanane skeleton of these compounds is essential for the potent inhibition of the edema response to capsaicin. This agrees with the results previ ously obtained from biochemical and pharmacological studies on the inhibitory effect of these compounds on lipoxygenase and cyclooxygenase activities (9) and on the inhibition of mouse ear edema induced by arachidonic acid (10) and TPA (12). In addition, the effect of these three compounds has been suggested to be a direct action and does not involve the anti-inflammatory action of steroids mediated by the formation of a reactive protein (10).
It has been suggested that SP released from sensory neurons plays an important role as a chemical mediator in capsaicin-induced skin inflammation (20, 21, 23). In con trast, arachidonate metabolites are minor factors in the edema response to capsaicin (20). The response to SP and compound 48/80 is also unaffected by pretreatment with indomethacin (20, 24) . Hence it appears that the inhibi tory effect of three compounds on capsaicin-induced ede ma is not due to an inhibition of the arachidonate path way at the inflammatory site.
SP is well-known to cause an inflammatory response by mediation of NKI-receptors (23, 25, 26) and by releasing vasoactive amines from mast cells (27, 28). Indeed, peripheral nerve endings and mast cells are in close spatial and functional association (29-31). Deoxoglycyrrhetol dihemiphthalate and the related compounds, at the same doses which prevented capsaicin-induced edema, exhibit ed a significant inhibition of ear edema induced by intra dermal injection of SP. However, capsaicin-evoked mast cell degranulation in skin connective tissue was unaffected when compound IIIa was administered before capsaicin application (H. Inoue, unpublished data). These observa tions provide evidence that the three compounds act at the postsynaptic level, but not at the presynaptic site, to inhibit the edema response to capsaicin. A previous study has shown that these compounds can prevent mouse paw edema and the contraction of isolated guinea pig ileum induced by histamine (13). This suggests that the inhibi tory effect of the compounds on edema formation evoked by capsaicin and intradermal SP is due at least in part to a prevention of the increase of vascular permeability in duced by histamine released from mast cells. This is sup ported by the finding that the three compounds inhibited ear edema induced by compound 48/80, a histamine liberator.
We have shown that compound IIIa prevented capsai cin-induced ear edema in mast cell-deficient mice. This indicates that the mode of action of the three compounds is not merely due to the suppression of the inflammatory response to mediators released from mast cells. Further more, we found that deoxoglycyrrhetol dihemiphthalate and related compounds at a high dose are able to inhibit the i.v. SP-induced plasma extravasation in ear skin. Chlorpheniramine exhibited a partial inhibition of the response induced by capsaicin and intradermal injection, but not by i.v. administration, of SP. It is, therefore, conceivable that histamine cannot primarily mediate the response to i.v. SP. On the other hand, in addition to the inhibition of the edema response to topical capsaicin and SP, RP 67580 (32), a non-peptide NK1-receptor an tagonist, blocked the ability of i.v. SP to augment vascu lar permeability in ear skin. Thus it seems that the response to i.v. SP is dependent on the mediation of NK1-receptors on postcapillary venules and arterioles (33). These findings suggest that three compounds can modulate vasodilatation and plasma extravasation in duced by SP involved in the capsaicin-induced ear edema, and this effect of the derivatives may play a role in the suppression of the response to capsaicin. However, in the present study, it is unclear whether the compounds affect the NK1-receptor in mouse skin.
On the basis of the present study, we conclude that deoxoglycyrrhetol dihemiphthalate and the related com pounds, the glycyrrhetinic acid derivatives, may be useful for the treatment of skin diseases including the neuro genic inflammatory response.
